ClinicalTrials.Veeva

Menu
A

Articularis Healthcare Group, Inc. | Low Country Rheumatology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Deucravacitinib
SAR441566
Branebrutinib
BMS-986165
MTX

Parent organization

This site is a part of Articularis Healthcare Group, Inc.

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 6 total trials

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

The purpose of this study is to evaluate the safety and efficacy of deucravacitinib versus placebo for the treatment of participants with active PsA...

Active, not recruiting
Psoriatic Arthritis
Drug: Apremilast
Other: Placebo
Locations recently updated

This is a parallel group, Phase 2, randomized, double-blind, placebo controlled, 5-arm, international, multicenter, 12-week proof of concept, dose fi...

Enrolling
Rheumatoid Arthritis
Drug: SAR441566
Drug: Placebo

The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus peglot...

Enrolling
Gout
Drug: Methotrexate
Biological: Pegloticase

Trial sponsors

Bristol-Myers Squibb (BMS) logo
Amgen logo
Sanofi logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems